Company record · GILD · Biological Products, (No Diagnostic Substances)
Gilead Sciences
The principal financial officer who signed Gilead Sciences's latest annual report is Andrew D. Dickinson, verified February 24, 2026.
Roster record
| Officer | Andrew D. Dickinson |
|---|---|
| Verified | February 24, 2026 (filing date of the source) |
| Note | The DEF 14A filed 2026-03-20 also names Andrew D. Dickinson alongside a Chief Financial Officer title. |
- sec.gov · signature block · “/s/ ANDREW D. DICKINSON Chief Financial Officer February 24, 2026 Andrew D. Dickinson (Principal Financial Officer)”
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.